---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-022592"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:20:48.095651+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics effects 1-for-12 reverse stock split effective August 4, 2025

## Summary
- Reverse stock split at ratio 1-for-12 became effective on August 4, 2025.
- No fractional shares issued; rounding up to nearest whole share; authorized shares unchanged at 330M common, 1M preferred.
- Stock continues trading under symbol CLDI on NYSE American with new CUSIP 320703408.
- Company states reverse split aims to optimize market dynamics and broaden investor appeal.
- All outstanding equity awards adjusted proportionally to reflect the reverse stock split.

## SEC filing metadata
- accession: 0001641172-25-022592
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000164117225022592/0001641172-25-022592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000164117225022592/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-022592
- JSON: https://secwatch.observer/filing/0001641172-25-022592.json
- Plain text: https://secwatch.observer/filing/0001641172-25-022592.txt

## Key facts
- Governance Changes
  Calidi Biotherapeutics, Inc.: Approved a 1-for-12 reverse stock split via Certificate of Amendment to the Certificate of Incorporation (effective 2025-08-04).
  - Change: charter amendment
  - Effective: 2025-08-04
  source text: The Reverse Stock Split was effected pursuant to the Company’s filing of a Certificate of Amendment (the “Certificate”) with the Secretary of State of the State of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855485/000164117225022592/0001641172-25-022592-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.